Medicines and clinical research approved in 2023
In 2023, Anvisa stepped up drug approvals, modernized regulations, implemented the QMS, prepared for WHO evaluation with the GBT and increased regulatory publications.
ELS can help you get your products on these charts! Count on us for registration and all the support you need for medicines.
ontact your local ELS consultant or via email info@elssolutions.pt
